← SynDRA
GANT-61
SynDRA canonical compound SYN0086638 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | GLI2 |
|---|
| Mechanism of action | GLI antagonist |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- GANT61
- CHEBI:140908
- RefChem:1058844
- DTXCID70280690
- GANT 61(NSC 136476)
- NSC136476
- MFCD14635408
- NSC-136476
- C27H35N5
- NCIStruc1_001747
- NCIStruc2_001814
- orb1304571
- SCHEMBL12831665
- SCHEMBL29432546
- CHEBI:94276
- EX-A339
- BDBM50249557
- CCG-37862
- HB3394
- NCGC00014352
- NCI136476
- AKOS024457467
- CS-1528
- SB19316
- GANT61(NSC 136476)?
- NCGC00014352-02
- NCGC00014352-03
- NCGC00014352-07
- NCGC00014352-14
- NCGC00097461-01
- AC-32720
- AS-57126
- DA-33611
- FG137676
- HY-13901
- SY357464
- S8075
- BRD-K09485525-001-02-1
- GANT61; GANT-61; GANT 61; NSC 136476
Look up GANT-61 in the interactive SynDRA portal →